Diosmin ( DrugBank: Diosmin )


3 diseases
告示番号疾患名(ページ内リンク)臨床試験数
46悪性関節リウマチ1
97潰瘍性大腸炎1
265脂肪萎縮症1

46. 悪性関節リウマチ


臨床試験数 : 4,356 薬物数 : 2,567 - (DrugBank : 415) / 標的遺伝子数 : 192 - 標的パスウェイ数 : 228
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries
1NCT05756179
(ClinicalTrials.gov)
July 202321/2/2023Effect of Diosmin and Hesperidin in Treatment of Patients With Rheumatoid ArthritisClinical Study Evaluating the Effect of Diosmin and Hesperidin in Treatment of Patients With Rheumatoid ArthritisRheumatoid ArthritisDrug: Diosmin and Hesperidin CombinationAlexandria UniversityNULLNot yet recruiting19 Years65 YearsAll80Phase 3NULL

97. 潰瘍性大腸炎


臨床試験数 : 2,630 薬物数 : 1,459 - (DrugBank : 265) / 標的遺伝子数 : 144 - 標的パスウェイ数 : 202
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries
1NCT05626166
(ClinicalTrials.gov)
November 20229/11/2022the Efficacy and Safety of Diosmin in Patients With Ulcerative ColitisClinical Study Evaluating the Efficacy and Safety of Diosmin in Patients With Ulcerative Colitis Treated With MesalamineUlcerative ColitisDrug: Placebo;Drug: DiosminTanta UniversityNULLNot yet recruiting18 YearsN/AAll60Phase 3NULL

265. 脂肪萎縮症


臨床試験数 : 112 薬物数 : 155 - (DrugBank : 55) / 標的遺伝子数 : 25 - 標的パスウェイ数 : 97
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries
1EUCTR2013-004539-57-PL
(EUCTR)
30/01/201416/12/2013A phase III, double-blind, placebo-controlled, randomized, three-arm parallel, study assessing efficacy and safety of 4 months of diosmin administration for the treatment of lower extremity teleangiectasias and gynoid lipodystrophy (edematous fibrosclerotic panniculopathy commonly known as cellulite)A phase III, double-blind, placebo-controlled, randomized, three-arm parallel, study assessing efficacy and safety of 4 months of diosmin administration for the treatment of lower extremity teleangiectasias and gynoid lipodystrophy (edematous fibrosclerotic panniculopathy commonly known as cellulite) lower extremity teleangiectasias and gynoid lipodystrophy (edematous fibrosclerotic panniculopathy commonly known as cellulite)
MedDRA version: 17.0;Level: LLT;Classification code 10065339;Term: Cellulite;System Organ Class: 100000004858
MedDRA version: 17.0;Classification code 10043193;Term: Telangiectasis;System Organ Class: 100000004858;Therapeutic area: Diseases [C] - Skin and Connective Tissue Diseases [C17]
Trade Name: Diosminex, 500 mg, tabletki powlekane
INN or Proposed INN: diosmin
Other descriptive name: DIOSMIN
ALIO MEDICA Sp. z o.o.NULLNot RecruitingFemale: yes
Male: no
Phase 3Poland